Herve Perron
40Patents
8h-index
55Co-inventors
78Inventor score
Filing activity: Feb 2, 1994 → Jun 17, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6270953A | Method for detecting and/or quantifying a gliotoxic factor | Physics | 20 | Expired |
| US5585262A | Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus | Physics | 16 | Expired |
| US6001987A | Isolated nucleotide sequences associated with Multiple sclerosis | Chemistry; Metallurgy | 15 | Expired |
| US6342383B1 | Cell lines and viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7081345B1 | Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease | Physics | 10 | Expired |
| US5800980A | Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7510843B2 | Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease | Physics | 9 | Active |
| US5876954A | Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5650318A | Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus | Physics | 7 | Expired |
| US5728540A | Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6184025A | Viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5871996A | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5871745A | Multiple sclerosis related virus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5962217A | MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6582703B2 | Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting | Chemistry; Metallurgy | 4 | Expired |
| US7674888B2 | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes | Chemistry; Metallurgy | 4 | Active |
| US7381817B2 | LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus | Chemistry; Metallurgy | 3 | Expired |
| US8715656B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 3 | Active |
| US5925555A | Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus | Physics | 2 | Expired |
| US6071736A | Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus | Physics | 2 | Expired |
| US9815888B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 2 | Active |
| US6291225A | Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus | Physics | 2 | Expired |
| US9550824B2 | Therapeutic use of specific ligand in MSRV associated diseases | Chemistry; Metallurgy | 2 | Active |
| US10723787B2 | Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody | Physics | 1 | Active |
| US7566530B2 | Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand | Physics | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.